Literature DB >> 8243859

Determinants of end-stage renal disease in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus and proteinuria.

R G Nelson1, W C Knowler, D R McCance, M L Sievers, D J Pettitt, M A Charles, R L Hanson, Q Z Liu, P H Bennett.   

Abstract

To identify factors related to the development of end-stage renal disease after the onset of proteinuria, its incidence was determined in 364 Pima Indians aged 35 years or older with Type 2 (non-insulin-dependent) diabetes mellitus and proteinuria (protein-to-creatinine ratio > or = 0.5 g/g). Of these 364 subjects, 95 (36 men, 59 women) developed end-stage renal disease. The cumulative incidence was 40% 10 years after and 61% 15 years after the onset of proteinuria. The incidence of end-stage renal disease was significantly related to the duration of diabetes, the duration of proteinuria, higher 2-h plasma glucose concentration, type of diabetes treatment, and the presence of retinopathy at the time of recognition of the proteinuria, but not to age, sex, or blood pressure. Duration of proteinuria influenced the risk of end-stage renal disease, contingent, however, upon the duration of diabetes at the onset of proteinuria. The higher cumulative incidence of end-stage renal disease 15 years after the onset of proteinuria in Pima Indians (61%) than in Caucasians from Rochester, Minnesota (17%) may be attributable, in part, to the younger age of onset of Type 2 diabetes in Pima Indians than in Caucasians, to ethnic differences in susceptibility to renal disease, or to lower death rates among the Pima Indians from competing causes of death, such as coronary heart disease.

Entities:  

Mesh:

Year:  1993        PMID: 8243859     DOI: 10.1007/bf02374503

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  55 in total

1.  Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients.

Authors:  A Schmitz; M Vaeth
Journal:  Diabet Med       Date:  1988-03       Impact factor: 4.359

2.  Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study.

Authors:  M J Garcia; P M McNamara; T Gordon; W B Kannel
Journal:  Diabetes       Date:  1974-02       Impact factor: 9.461

3.  Clinical course of myocardial infarction among diabetic patients.

Authors:  A Czyzyk; A S Królewski; S Szabłowska; A Alot; J Kopczyński
Journal:  Diabetes Care       Date:  1980 Jul-Aug       Impact factor: 19.112

4.  Use of single voided urine samples to estimate quantitative proteinuria.

Authors:  J M Ginsberg; B S Chang; R A Matarese; S Garella
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

5.  Renal function in non-insulin-dependent diabetes mellitus: purposes and design of the Diabetic Renal Disease Study.

Authors:  R G Nelson
Journal:  Acta Diabetol       Date:  1991       Impact factor: 4.280

6.  Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians.

Authors:  R G Nelson; J A Wolfe; M B Horton; D J Pettitt; P H Bennett; W C Knowler
Journal:  Diabetes       Date:  1989-04       Impact factor: 9.461

7.  Atherosclerotic vascular disease in middle-aged, insulin-treated, diabetic patients. Association with endogenous insulin secretion capacity.

Authors:  T Rönnemaa; M Laakso; P Puukka; V Kallio; K Pyörälä
Journal:  Arteriosclerosis       Date:  1988 May-Jun

8.  Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus.

Authors:  K Dahl-Jørgensen; T Bjøro; P Kierulf; L Sandvik; H J Bangstad; K F Hanssen
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

9.  Insulin treatment, endogenous insulin concentration, and ECG abnormalities in diabetic Pima Indians. Cross-sectional and prospective analyses.

Authors:  Q Z Liu; W C Knowler; R G Nelson; M F Saad; M A Charles; I M Liebow; P H Bennett; D J Pettitt
Journal:  Diabetes       Date:  1992-09       Impact factor: 9.461

10.  Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy.

Authors:  C E Mogensen
Journal:  Br Med J (Clin Res Ed)       Date:  1982-09-11
View more
  9 in total

1.  Hypertension in Pima Indians: prevalence and predictors.

Authors:  M P de Courten; D J Pettitt; W C Knowler
Journal:  Public Health Rep       Date:  1996       Impact factor: 2.792

2.  Podocyte loss and progressive glomerular injury in type II diabetes.

Authors:  M E Pagtalunan; P L Miller; S Jumping-Eagle; R G Nelson; B D Myers; H G Rennke; N S Coplon; L Sun; T W Meyer
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

3.  Association of variants in the carnosine peptidase 1 gene (CNDP1) with diabetic nephropathy in American Indians.

Authors:  Harini A Chakkera; Robert L Hanson; Sayuko Kobes; Meredith P Millis; Robert G Nelson; William C Knowler; Johanna K Distefano
Journal:  Mol Genet Metab       Date:  2011-02-19       Impact factor: 4.797

Review 4.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

5.  Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.

Authors:  Gudeta D Fufaa; E Jennifer Weil; Kevin V Lemley; William C Knowler; Frank C Brosius; Berne Yee; Michael Mauer; Robert G Nelson
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-20       Impact factor: 8.237

Review 6.  Diabetic nephropathy: Is it time yet for routine kidney biopsy?

Authors:  Maria L Gonzalez Suarez; David B Thomas; Laura Barisoni; Alessia Fornoni
Journal:  World J Diabetes       Date:  2013-12-15

Review 7.  Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications.

Authors:  Federica Piani; Isabella Melena; Kalie L Tommerdahl; Natalie Nokoff; Robert G Nelson; Meda E Pavkov; Daniël H van Raalte; David Z Cherney; Richard J Johnson; Kristen J Nadeau; Petter Bjornstad
Journal:  J Diabetes Complications       Date:  2020-12-31       Impact factor: 2.852

8.  Intraglomerular Dysfunction Predicts Kidney Failure in Type 2 Diabetes.

Authors:  Pierre J Saulnier; Helen C Looker; Michael Mauer; Behzad Najafian; Elise Gand; Stephanie Ragot; Robert G Nelson; Petter Bjornstad
Journal:  Diabetes       Date:  2021-07-13       Impact factor: 9.337

Review 9.  Pima Indian Contributions to Our Understanding of Diabetic Kidney Disease.

Authors:  Robert G Nelson; William C Knowler; Matthias Kretzler; Kevin V Lemley; Helen C Looker; Michael Mauer; William E Mitch; Behzad Najafian; Peter H Bennett
Journal:  Diabetes       Date:  2021-07-20       Impact factor: 9.337

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.